Business Development Dermatology Hormones Licensing 
The Pharma Data
AUGUST 3, 2021
We expect that recovery in the dermatology segment will continue to progress over the coming quarters. Research & Development (R&D) expenses increased 12% primarily due to higher research and early pipeline spend and late-stage development program spend, including our recent business development activities.
XTalks
AUGUST 2, 2023
They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. The private sector price of Prevnar 20 is around $253.96 Pfizer’s total global revenue from Ibrance was $5.12
Expert insights. Personalized for you.
52 
Let's personalize your content